目次

Table of Content

1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3. Biopharmaceutical Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot

2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation

3. Market Characteristics
3.1. Market Definition
3.2.Biopharmaceutical Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data

4. Biopharmaceutical Market - Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability

5. Macroeconomic Indicators

6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends

8. Risk Analysis

9. Market Analysis
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological

10. Biopharmaceutical Market
10.1.Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Biopharmaceutical Market Size & Forecast 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Product Type
11.3.1.1. Purified Proteins
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Recombinant Growth Factors
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Recombinant Proteins
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Recombinant Hormone
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5.Synthetic Immunomodulatory
11.3.1.5.1.By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.6.Monoclonal Antibodies
11.3.1.6.1.By Value (USD Million) 2022-2032F
11.3.1.6.2. Market Share (%) 2022-2032F
11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.7.Vaccines
11.3.1.7.1.By Value (USD Million) 2022-2032F
11.3.1.7.2. Market Share (%) 2022-2032F
11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.8.Other
11.3.1.8.1.By Value (USD Million) 2022-2032F
11.3.1.8.2. Market Share (%) 2022-2032F
11.3.1.8.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Service
11.3.2.1.Custom Testing / Customer Proprietary Testing
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Laboratory Testing
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Compendial, and Multi Compendial Laboratory Testing
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3. By Raw Material Type
11.3.3.1.Active Pharmaceutical Ingredients (API)
11.3.3.1.1.By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Formulation Excipients
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2.Market Share (%) 2022-2032F
11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2.Market Share (%) 2022-2032F
11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.4. By Application
11.3.4.1.Autoimmune Disorders
11.3.4.1.1.By Value (USD Million) 2022-2032F
11.3.4.1.2. Market Share (%) 2022-2032F
11.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.2. Metabolic Disorders
11.3.4.2.1. By Value (USD Million) 2022-2032F
11.3.4.2.2.Market Share (%) 2022-2032F
11.3.4.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.3. Oncology
11.3.4.3.1. By Value (USD Million) 2022-2032F
11.3.4.3.2. Market Share (%) 2022-2032F
11.3.4.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.4. Inflammatory and Infectious Diseases
11.3.4.4.1.By Value (USD Million) 2022-2032F
11.3.4.4.2. Market Share (%) 2022-2032F
11.3.4.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.5. Hormonal Disorders
11.3.4.5.1.By Value (USD Million) 2022-2032F
11.3.4.5.2. Market Share (%) 2022-2032F
11.3.4.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.6. Neurological Diseases
11.3.4.6.1. By Value (USD Million) 2022-2032F
11.3.4.6.2.Market Share (%) 2022-2032F
11.3.4.6.3.Y-o-Y Growth (%) 2022-2032F
11.3.4.7. Cardiovascular Diseases
11.3.4.7.1. By Value (USD Million) 2022-2032F
11.3.4.7.2.Market Share (%) 2022-2032F
11.3.4.7.3.Y-o-Y Growth (%) 2022-2032F
11.3.4.8. Other
11.3.4.8.1.By Value (USD Million) 2022-2032F
11.3.4.8.2. Market Share (%) 2022-2032F
11.3.4.8.3. Y-o-Y Growth (%) 2022-2032F

12. North America Biopharmaceutical Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product Type
12.3.2.By Service
12.3.3.By Raw Material Type
12.3.4.By Application
12.4. Country
12.4.1.United States
12.4.2. Canada

13. Europe Biopharmaceutical Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product Type
13.3.2.By Service
13.3.3.By Raw Material Type
13.3.4.By Application
13.4. Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14. Asia Biopharmaceutical Market Size & Forecast 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product Type
14.3.2.By Service
14.3.3.By Raw Material Type
14.3.4. By Application
14.4. Country
14.4.1.India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC

15. Middle East and Africa Biopharmaceutical Market Size & Forecast 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product Type
15.3.2.By Service
15.3.3.By Raw Material Type
15.3.4.By Application
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa

16. Latin America Biopharmaceutical Market Size & Forecast 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product Type
16.3.2.By Service
16.3.3.By Raw Material Type
16.3.4.By Application
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America

17. Competitive Landscape
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders

18. Company Profiles
18.1.Amgen Inc.
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. AstraZeneca
18.3. Johnson & Johnson Private Limited
18.4.Lilly
18.5. Pfizer Inc.
18.6. Sanofi
18.7. Abbott
18.8.Novartis AG
18.9. F. Hoffmann-La Roche Ltd.
18.10.Novo Nordisk A/S
18.11.bioMérieux
18.12.Merck & Co., Inc.
18.13.Bristol-Myers Squibb Company
18.14.GlaxoSmithKline Plc
18.15.Bayer AG
18.16. Biogen
18.17. Other Prominent Players

19. Appendix

20.Consultant Recommendation